According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...
Healthcare Asia Magazine on MSN
Biomarkers market to top $112B by 2031 on drug discovery demand
Consumables held the largest share at 73.4% in 2025. The global biomarkers market is projected to grow to $112.1b by 2031, ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
Morning Overview on MSN
Scientists traced why H5N1 bird flu hits cows’ udders instead of their lungs
Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...
RNA has emerged as one of the most promising molecules in modern medicine, enabling advances from mRNA vaccines and gene ...
Esophageal cancer, which is cancer of the swallowing tube, has only a 22.2% five-year relative survival rate, but early ...
The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...
Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist ...
By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing ...
RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results